Do you think we might be range bound for a while due to the election cycle or do you think biotech news in the next 3 months will be sufficient to carry the day through the summer months leading up to the election? Valeant might weigh? Just trying to get a handle on what I see happening and to me a quick rebound seems less likely than a normal cycle would create. Best wishes.
News 
Market Data 
Discover 
AI
